http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Biotricity Issues COVID-19 Update
-
Biotricity Launches Innovative Pain Management Product with NeuPath Health
-
Legendary Cardiologist and Serial Entrepreneur Dr. John Simpson to Chair Biotricity’s Scientific & Medical Alliance Board
-
Biotricity Posts Calendar Q4 Results that Show Continued Growth
-
Biotricity Files a 510(k) Application for its Advanced ECG Analysis Software
-
Biotricity Prepares its Filing for a 510(k) Application for its Advanced ECG Analysis Software
-
Biotricity Converts $1.8 Million of Private Investor Notes into Preferred Equity
-
Biotricity Completes $6M Investment from Private Investor
-
Biotricity Completes Development of its ECG Patch Platform
-
Biotricity Shows Continued Growth in Core Revenue for Fiscal Q2
-
Biotricity CEO Waqaas Al-Siddiq in Live Interview on FOX Business Network
-
BiotricityReports Fiscal Q1 ResultsShowingA Strong Growth Trajectory
-
Biotricity CEO Waqaas Al-Siddiq in Live Interview on Yahoo Finance
-
Biotricity Audited Year-End Results Demonstrate Execution of Commercial Growth Plans
-
Biotricity Doubles Sales Force – Expands Device Fleet by 59%
-
Biotricity Provides Fiscal Fourth Quarter Update: Sales Force Expansion to Fuel Growth
-
Biotricity Achieves Market Expansion in Two New States
-
Biotricity Announces Expanded R&D Team for the Development of its Fetal/Maternal and Ambulatory Wellness Monitoring Systems
-
Biotricity Provides End of Year Shareholder Update
-
Biotricity Actively Pursues Holter Market with Bioflux Product Offering
-
Biotricity Builds Capacity with University of Calgary and Receives Ethics Approvals for Research
-
Distinguished Physicians Join Biotricity’s Newly Formed Scientific and Medical Alliance Board
-
Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications
-
Biotricity Provides Fiscal 2018 Second Quarter Updates for Shareholders
-
Biotricity Developing ECG Patch for Anticipated Q1 2019 Release
-
Biotricity Completes Alpha Version of Deep Data Diagnostic Solution
-
Biotricity Provides Fiscal 2018 First Quarter Updates for Shareholders
-
Biotricity’s Bioflux Named Best Remote Patient Monitoring Solution by MedTech Breakthrough
-
Biotricity Achieves Revenue Generation and Market Expansion with Anchor Clients
-
San Antonio Endovascular & Heart Institute First to Deploy Biotricity’s New Bioflux Remote Monitoring Device
-
Biotricity Reviews Fiscal Year 2017 Milestones and Outlines 2018 Goals
-
Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch
-
Biotricity Announces Commercial Rollout of Proprietary Bioflux Device
-
Biotricity Update for Shareholders
-
Medical-Grade Wearable Provider Biotricity Aims to Increase Patient Adherence
-
Biotricity Announces the Addition of Artificial Intelligence to its Remote Patient Monitoring Platform
-
Biotricity Expands its R&D Effort to Capitalize on Artificial Intelligence
-
Biotricity Announces Expansion of Bioflux Sales Force and Pilot Sites
-
Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch
-
Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device
-
Biotricity Recognizes Remote Monitoring is Key to Chronic Care Management
-
Biotricity FDA Submission Update
-
Biotricity CEO and Advisory Board Member to Speak at Major Health Tech Conferences
-
Biotricity Expands Team with New CFO as it Prepares for Commercialization
-
Biotricity Q3 Update for Shareholders
-
Biotricity Announces Support of Progressive Changes in Telemedicine Healthcare Policy
-
Biotricity Receives Ethics Approval to Investigate Mobile Wireless Fetal Monitoring
-
Biotricity Provides Mid-Year Update for Shareholders
